LEXICON PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Lexicon Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2015 to Q3 2024.
  • Lexicon Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 361M shares, a 47.6% increase year-over-year.
  • Lexicon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 221M shares, a 33.4% increase from 2022.
  • Lexicon Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 166M shares, a 13.8% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 361M +117M +47.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 311M +106M +51.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 245M +56.4M +29.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 221M +55.4M +33.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 245M +70M +40% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 205M +55.2M +36.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 189M +39.9M +26.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 166M +20.1M +13.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 175M +29.1M +19.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 150M +5.17M +3.58% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 149M +5.77M +4.03% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 146M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-25
Q3 2021 146M +38.5M +35.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 144M +37.4M +34.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 143M +36.8M +34.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 107M +1.04M +0.98% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 107M +801K +0.75% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 107M +482K +0.45% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 106M +391K +0.37% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 106M Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 106M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-27
Q3 2018 106M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q4 2015 104M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 104M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 104M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 104M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.